BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3124710)

  • 1. Current status of thyrotropin-releasing hormone therapy in amyotrophic lateral sclerosis. Committee on Health Care Issues, American Neurological Association.
    Ann Neurol; 1987 Oct; 22(4):541-3. PubMed ID: 3124710
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary clinical study on the treatment of amyotrophic lateral sclerosis with TRH].
    Formisano R; Antonini G; Bove R; Millefiorini M; Ruggieri S
    Clin Ter; 1986 Dec; 119(6):479-81. PubMed ID: 3102155
    [No Abstract]   [Full Text] [Related]  

  • 3. Amyotrophic lateral sclerosis: a double-blind crossover trial of thyrotropin-releasing hormone.
    Imoto K; Saida K; Iwamura K; Saida T; Nishitani H
    J Neurol Neurosurg Psychiatry; 1984 Dec; 47(12):1332-4. PubMed ID: 6439824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal thyrotropin-releasing hormone in amyotrophic lateral sclerosis.
    Munsat TL; Taft J; Kasdon D
    Neurol Clin; 1987 Feb; 5(1):159-70. PubMed ID: 3104751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of amyotrophic lateral sclerosis with thyrotropin releasing hormone].
    Serratrice G; Desnuelle C; Crevat A; Guelton C; Meyer-Dutour A
    Rev Neurol (Paris); 1986; 142(2):133-9. PubMed ID: 3088700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Brooke MH; Florence JM; Heller SL; Kaiser KK; Phillips D; Gruber A; Babcock D; Miller JP
    Neurology; 1986 Feb; 36(2):146-51. PubMed ID: 3080694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Note on the use of TRH in amyotrophic lateral sclerosis].
    Serratrice G
    Bull Acad Natl Med; 1985 Oct; 169(7):1013-7. PubMed ID: 3938669
    [No Abstract]   [Full Text] [Related]  

  • 8. Intrathecal thyrotropin-releasing hormone therapy of amyotrophic lateral sclerosis.
    Stober T; Schimrigk K; Dietzsch S; Thielen T
    J Neurol; 1985; 232(1):13-4. PubMed ID: 3923160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapies in motor neurone disease.
    Goonetilleke A
    Br J Hosp Med; 1995 Apr 5-18; 53(7):314-7. PubMed ID: 7788066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic trial of intrathecal thyrotropin-releasing hormone (TRH) and a TRH-analogue in amyotrophic lateral sclerosis (ALS).
    Thielen T; Stober T; Schimrigk K
    Adv Exp Med Biol; 1987; 209():305-8. PubMed ID: 3107352
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis.
    Caroscio JT; Cohen JA; Zawodniak J; Takai V; Shapiro A; Blaustein S; Mulvihill MN; Loucas SP; Gudesblatt M; Rube D
    Neurology; 1986 Feb; 36(2):141-5. PubMed ID: 3080693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New hormone therapy. Thyrotropin releasing hormone].
    Sobue I
    Nihon Rinsho; 1987 Nov; 45(11):2671-8. PubMed ID: 3127616
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
    Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P
    Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spinal mechanism of the antispastic action of TRH in patients with amyotrophic lateral sclerosis].
    Morin C; Pierrot-Deseilligny E
    Rev Neurol (Paris); 1988; 144(11):701-3. PubMed ID: 3148185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of amyotrophic lateral sclerosis with TRH].
    Klimek A; Szulc-Kuberska J; Czernielewska-Rutkowska I; Głuszcz-Zielińska A
    Neurol Neurochir Pol; 1988; 22(3):206-10. PubMed ID: 3146705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trial of thyrotropin-releasing factor in amyotrophic lateral sclerosis].
    Serratrice G; Desnuelle C; Guelton C; Meyer-Dutour A; Richard P; Braguer D; Crevat A
    Presse Med; 1985 Feb; 14(8):487-8. PubMed ID: 3157152
    [No Abstract]   [Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials.
    Mitsumoto H; Salgado ED; Negroski D; Hanson MR; Salanga VD; Wilber JF; Wilbourn AJ; Breuer AC; Leatherman J
    Neurology; 1986 Feb; 36(2):152-9. PubMed ID: 3080695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary effects of thyrotropin-releasing hormone in amyotrophic lateral sclerosis.
    Braun SR; Sufit RL; Brooks BR
    Lancet; 1984 Sep; 2(8401):529-30. PubMed ID: 6147597
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyrotrophin-releasing hormone. New applications in the clinic.
    Griffiths EC
    Nature; 1986 Jul 17-23; 322(6076):212-3. PubMed ID: 3090448
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trials of 1-cysteine, TRH and 5HTP in amyotrophic lateral sclerosis].
    Akiguchi I; Kato T; Sugiyama H
    Rinsho Shinkeigaku; 1984 Dec; 24(12):1270-3. PubMed ID: 6442975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.